Levi Strauss & Co (NYSE:LEVI) saw its shares jump 7% in premarket trading after reporting better-than-expected second-quarter results and raising its full-year earnings forecast. The strong performance was fueled by robust consumer demand and effective business execution.
The iconic denim brand posted Q2 earnings per share (EPS) of $0.22, surpassing Wall Street’s estimate of $0.13. Revenue climbed to $1.4 billion, beating expectations of $1.37 billion. The results reflect ongoing momentum in Levi’s strategic shift toward higher-margin products and premium distribution channels.
CFO Harmit Singh noted the company’s solid first-half performance and broad-based strength across regions and categories. “Despite the impact of higher tariffs, we are confident in raising our full-year revenue and EPS guidance,” Singh said.
Levi now anticipates full-year 2025 EPS between $1.25 and $1.30, above analysts’ consensus of $1.23. This improved outlook, even amid trade-related headwinds, underscores Levi’s resilient supply chain and diversified sourcing strategy.
Stifel analysts praised the Q2 performance, highlighting it as a key proof point of Levi’s long-term strategy to elevate brand value and expand into more profitable segments. They emphasized that despite tariff uncertainties, Levi is well-positioned to manage future cost pressures, potentially offsetting most impacts by 2026.
Levi’s earnings beat and raised guidance signal strong consumer demand and successful execution of its premium-focused transformation. The stock’s premarket rally reflects investor optimism around the company’s growth trajectory and ability to navigate macroeconomic challenges.
With solid fundamentals, diversified sourcing, and a positive earnings outlook, Levi Strauss remains a standout in the apparel sector for 2025.


Washington Post Publisher Will Lewis Steps Down After Layoffs
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



